Immunological Effects of Anti‒IL-17/12/23 Therapy in Patients with Psoriasis Complicated by Candida Infections-Reference-Cited by-同舟云学术

Immunological Effects of Anti‒IL-17/12/23 Therapy in Patients with Psoriasis Complicated by Candida Infections

Published:2022-11 Issue:11 Volume:142 Page:2929-2939.e8
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Bruno Mariolina^ORCID,Davidson Linda^ORCID,Koenen Hans J.P.M.^ORCID,van den Reek Juul M.P.A.^ORCID,van Cranenbroek Bram,de Jong Elke M.G.J.^ORCID,van de Veerdonk Frank L.^ORCID,Kullberg Bart-Jan^ORCID,Netea Mihai G.^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference51 articles.

1. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells;Acosta-Rodriguez;Nat Immunol,2007

2. Differential effects of environmental and genetic factors on T and B cell immune traits;Aguirre-Gamboa;Cell Rep,2016

3. Pathophysiology, clinical presentation, and treatment of psoriasis: a review;Armstrong;JAMA,2020

4. A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis;Bilal;J Dermatolog Treat,2018

5. Psoriasis;Boehncke;Lancet,2015

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-17 in skin infections and homeostasis;Clinical Immunology;2024-10

2. Fungal vaccines and adjuvants: a tool to reveal the interaction between host and fungi;Archives of Microbiology;2024-06-08

3. Interleukins and Psoriasis;Journal of Cutaneous Medicine and Surgery;2024-02-05

4. Incidence of New-Onset Inflammatory Bowel Disease, Oral and Gastrointestinal Candidiasis, Herpes Zoster, Pulmonary Tuberculosis, and Major Cardiovascular Events in Patients with Moderate-to-Severe Psoriasis Exposed to Biologics;Journal of Clinical Medicine;2023-12-13

5. Pro‐inflammatory cytokine IL‐6 regulates LMO4 expression in psoriatic keratinocytes via AKT/STAT3 pathway;Immunity, Inflammation and Disease;2023-12